Crossmark

Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma

Crossref DOI link: https://doi.org/10.1007/s11604-018-0774-8

Published Online: 2018-09-11

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Komatsu, Tetsuya

Konishi, Kenta

Aoshima, Masahiro

Tokura, Yoshiki

Nakamura, Katsumasa
Funding

Funding for this research was provided by:

JSPS KAKENHI (16H05389)
License Information

Text and Data Mining valid from 2018-09-11
More Information

Article History

Received: 11 June 2018

Accepted: 5 September 2018

First Online: 11 September 2018

Compliance with ethical standards

:

: The authors declare that there is no conflict of interest.

: All procedures performed in this study involving human participants were in accordance with the ethical standards of our institutional research committee and with the 1964 Declaration of Helsinki and its later amendments. This study was approved by the Institutional Review Board of our hospital (no. 17-169). All applicable institutional and national guidelines for the care were followed.